Concomitant JAK2 mutated myeloproliferative neoplasms and hereditary hemochromatosis

Int J Lab Hematol. 2022 Dec;44(6):999-1000. doi: 10.1111/ijlh.13902. Epub 2022 May 27.

Authors

Giuseppe G Loscocco^{1

2}, Raffaella Santi³, Valentina Carrai⁴, Giacomo Coltro¹, Francesco Mannelli¹, Paola Guglielmelli¹, Alessandro M Vannucchi¹

Affiliations

¹ Department of Experimental and Clinical Medicine, CRIMM, Center of Research, and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
² Doctorate School GenOMec, University of Siena, Siena, Italy.
³ Department of Health Sciences, University of Florence, Florence, Italy.
⁴ Hematology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

No abstract available

Publication types

Case Reports

MeSH terms

Hemochromatosis* / diagnosis
Hemochromatosis* / genetics
Humans
Janus Kinase 2 / genetics
Mutation
Myeloproliferative Disorders* / genetics
Neoplasms*

Substances

Janus Kinase 2
JAK2 protein, human